NASDAQ:LPNT - LifePoint Health Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$55.40 +0.15 (+0.27 %)
(As of 05/22/2018 01:50 AM ET)
Previous Close$55.25
Today's Range$55.05 - $56.20
52-Week Range$41.45 - $67.95
Volume322,700 shs
Average Volume527,233 shs
Market Capitalization$2.14 billion
P/E Ratio15.26
Dividend YieldN/A
Beta0.5

About LifePoint Health (NASDAQ:LPNT)

LifePoint Health logoLifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. The company's hospitals also offer outpatient services comprising same-day surgery, laboratory, X-ray, respiratory therapy, imaging, sports medicine, and lithotripsy. In addition, it owns and operates schools of nursing and other allied health professions. As of December 31, 2017, the company operated 71 hospital campuses with a total of 9,254 licensed beds in 22 states. The company was formerly known as LifePoint Hospitals, Inc. and changed its name to LifePoint Health, Inc. in May 2015. LifePoint Health, Inc. was founded in 1997 and is based in Brentwood, Tennessee.

Receive LPNT News and Ratings via Email

Sign-up to receive the latest news and ratings for LPNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolNASDAQ:LPNT
CUSIP53219L10
Phone615-920-7000

Debt

Debt-to-Equity Ratio1.28
Current Ratio1.76
Quick Ratio1.55

Price-To-Earnings

Trailing P/E Ratio15.26
Forward P/E Ratio12.88
P/E Growth1.46

Sales & Book Value

Annual Sales$7.26 billion
Price / Sales0.30
Cash Flow$12.6773 per share
Price / Cash4.37
Book Value$57.99 per share
Price / Book0.96

Profitability

EPS (Most Recent Fiscal Year)$3.63
Net Income$102.40 million
Net Margins0.48%
Return on Equity6.56%
Return on Assets2.39%

Miscellaneous

Employees42,000
Outstanding Shares38,780,000

LifePoint Health (NASDAQ:LPNT) Frequently Asked Questions

What is LifePoint Health's stock symbol?

LifePoint Health trades on the NASDAQ under the ticker symbol "LPNT."

How will LifePoint Health's stock buyback program work?

LifePoint Health announced that its board has authorized a share repurchase program on Friday, October 27th 2017, which authorizes the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company's board believes its stock is undervalued.

How were LifePoint Health's earnings last quarter?

LifePoint Health (NASDAQ:LPNT) posted its earnings results on Friday, May, 4th. The company reported $1.22 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.13 by $0.09. The firm earned $1.60 billion during the quarter, compared to analysts' expectations of $1.62 billion. LifePoint Health had a net margin of 0.48% and a return on equity of 6.56%. The company's quarterly revenue was down 1.7% on a year-over-year basis. During the same period in the prior year, the company earned $1.07 earnings per share. View LifePoint Health's Earnings History.

What guidance has LifePoint Health issued on next quarter's earnings?

LifePoint Health issued an update on its FY18 earnings guidance on Friday, February, 23rd. The company provided earnings per share guidance of $4.00-4.53 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.09. The company issued revenue guidance of $6.35-6.43 billion, compared to the consensus revenue estimate of $6.49 billion.

What price target have analysts set for LPNT?

17 brokers have issued 12 month target prices for LifePoint Health's stock. Their forecasts range from $45.00 to $66.00. On average, they expect LifePoint Health's stock price to reach $53.5714 in the next year. View Analyst Ratings for LifePoint Health.

What are Wall Street analysts saying about LifePoint Health stock?

Here are some recent quotes from research analysts about LifePoint Health stock:
  • 1. Cantor Fitzgerald analysts commented, "LPNT reported in-line 4Q17 results, with revenue that is short of the FactSet consensus but adjusted EBITDA that was in-line. The company has, however, increased its provision for bad debt, and includes the new, more accurate estimate as an adjustment." (2/23/2018)
  • 2. According to Zacks Investment Research, "LifePoint Health’s stock has underperformed the industry in a year’s time, but its strong Value Score, attractive valuation and upward revision in earnings estimates presents a good investment opportunity. The company’s inorganic growth strategies have aided its overall growth. Disciplined share buyback also provides support to its bottom line. Nevertheless, the company trimmed its 2017 guidance for the second time on a challenging volume environment and weak revenue growth. The company is faced with increasing expenses which has outpaced revenue growth thereby squeezing operating margins. High bad debt is another concern as is declining cash flows." (1/22/2018)

Who are some of LifePoint Health's key competitors?

Who are LifePoint Health's key executives?

LifePoint Health's management team includes the folowing people:
  • Mr. William F. Carpenter III, Chairman & CEO (Age 63)
  • Mr. David M. Dill, Pres & COO (Age 49)
  • Mr. Michael S. Coggin, Exec. VP, CFO & Principal Accounting Officer (Age 48)
  • Mr. John P. Bumpus, Exec. VP & Chief Admin. Officer (Age 57)
  • Mr. Sean Tuley, Sr. VP & CIO

Has LifePoint Health been receiving favorable news coverage?

Media stories about LPNT stock have been trending somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LifePoint Health earned a news impact score of 0.17 on Accern's scale. They also gave press coverage about the company an impact score of 47.37 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are LifePoint Health's major shareholders?

LifePoint Health's stock is owned by many different of institutional and retail investors. Top institutional investors include American Century Companies Inc. (11.29%), BlackRock Inc. (8.88%), Dimensional Fund Advisors LP (8.52%), LSV Asset Management (5.78%), CARPENTER WILLIAM F III (5.30%) and Diamond Hill Capital Management Inc. (4.15%). Company insiders that own LifePoint Health stock include David M Dill, John E D D S Maupin Jr, John P Bumpus, Marguerite Kondracke, Richard H Evans and William F Carpenter III. View Institutional Ownership Trends for LifePoint Health.

Which institutional investors are selling LifePoint Health stock?

LPNT stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, WINTON GROUP Ltd, Prudential Financial Inc., Citigroup Inc., Dimensional Fund Advisors LP, California Public Employees Retirement System, Boston Partners and Diamond Hill Capital Management Inc.. Company insiders that have sold LifePoint Health company stock in the last year include David M Dill, Marguerite Kondracke and William F Carpenter III. View Insider Buying and Selling for LifePoint Health.

Which institutional investors are buying LifePoint Health stock?

LPNT stock was purchased by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., American Century Companies Inc., LSV Asset Management, Massachusetts Financial Services Co. MA, Letko Brosseau & Associates Inc., Hussman Strategic Advisors Inc., Russell Investments Group Ltd. and Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp. View Insider Buying and Selling for LifePoint Health.

How do I buy shares of LifePoint Health?

Shares of LPNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LifePoint Health's stock price today?

One share of LPNT stock can currently be purchased for approximately $55.40.

How big of a company is LifePoint Health?

LifePoint Health has a market capitalization of $2.14 billion and generates $7.26 billion in revenue each year. The company earns $102.40 million in net income (profit) each year or $3.63 on an earnings per share basis. LifePoint Health employs 42,000 workers across the globe.

How can I contact LifePoint Health?

LifePoint Health's mailing address is 330 Seven Springs Way, Brentwood TN, 37027. The company can be reached via phone at 615-920-7000 or via email at [email protected]


MarketBeat Community Rating for LifePoint Health (LPNT)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  302 (Vote Outperform)
Underperform Votes:  476 (Vote Underperform)
Total Votes:  778
MarketBeat's community ratings are surveys of what our community members think about LifePoint Health and other stocks. Vote "Outperform" if you believe LPNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LPNT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

LifePoint Health (NASDAQ:LPNT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for LifePoint Health in the last 12 months. Their average twelve-month price target is $53.5714, suggesting that the stock has a possible downside of 3.30%. The high price target for LPNT is $66.00 and the low price target for LPNT is $45.00. There are currently 1 sell rating, 10 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.292.282.222.31
Ratings Breakdown: 1 Sell Rating(s)
10 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
11 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
12 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
11 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $53.5714$53.0667$57.6429$59.1667
Price Target Upside: 3.30% downside11.95% upside17.40% upside36.96% upside

LifePoint Health (NASDAQ:LPNT) Consensus Price Target History

Price Target History for LifePoint Health (NASDAQ:LPNT)

LifePoint Health (NASDAQ:LPNT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/7/2018SunTrust BanksReiterated RatingHold$58.00LowView Rating Details
3/27/2018Robert W. BairdReiterated RatingBuy$54.00MediumView Rating Details
3/23/2018MizuhoInitiated CoverageNeutralHighView Rating Details
3/16/2018Wolfe ResearchUpgradeUnderperform ➝ Peer PerformMediumView Rating Details
3/15/2018Raymond JamesUpgradeMarket Perform ➝ Outperform$57.00HighView Rating Details
3/15/2018UBSUpgradeMarket Perform ➝ OutperformHighView Rating Details
3/5/2018Leerink SwannDowngradeOutperform ➝ Market Perform$46.30 ➝ $58.00MediumView Rating Details
2/26/2018Royal Bank of CanadaLower Price TargetOutperform$58.00HighView Rating Details
2/26/2018BMO Capital MarketsLower Price TargetMarket Perform$47.00HighView Rating Details
2/26/2018Credit Suisse GroupReiterated RatingNeutral ➝ Neutral$54.00 ➝ $48.00HighView Rating Details
2/26/2018Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$50.00 ➝ $46.00HighView Rating Details
2/23/2018Cantor FitzgeraldReiterated RatingHold$50.00HighView Rating Details
1/30/2018Wells FargoInitiated CoverageMarket Perform ➝ Market Perform$52.00HighView Rating Details
1/3/2018Goldman SachsInitiated CoverageSell ➝ Sell$45.00HighView Rating Details
11/21/2017William BlairReiterated RatingOutperformN/AView Rating Details
10/30/2017CitigroupLower Price TargetBuy$70.00 ➝ $60.00N/AView Rating Details
10/29/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/4/2017Piper Jaffray CompaniesReiterated RatingHold$66.00MediumView Rating Details
5/1/2017BarclaysBoost Price TargetEqual Weight$58.00 ➝ $60.00LowView Rating Details
4/4/2017Deutsche BankInitiated CoverageHold ➝ Hold$68.00LowView Rating Details
11/9/2016Avondale PartnersDowngradeOutperform ➝ Market PerformN/AView Rating Details
11/9/2016Bank of AmericaDowngradeNeutral ➝ Underperform$66.00 ➝ $59.00N/AView Rating Details
8/1/2016WedbushReiterated RatingNeutral$80.00 ➝ $66.00N/AView Rating Details
(Data available from 5/22/2016 forward)

Earnings

LifePoint Health (NASDAQ:LPNT) Earnings History and Estimates Chart

Earnings by Quarter for LifePoint Health (NASDAQ:LPNT)

LifePoint Health (NASDAQ:LPNT) Earnings Estimates

2018 EPS Consensus Estimate: $4.21
2019 EPS Consensus Estimate: $4.51
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$1.01$1.13$1.07
Q2 20185$0.96$1.10$1.05
Q3 20184$0.95$1.05$1.00
Q4 20185$0.98$1.15$1.08
Q1 20194$1.10$1.22$1.16
Q2 20194$1.03$1.20$1.12
Q3 20194$1.05$1.08$1.06
Q4 20192$1.16$1.17$1.17

LifePoint Health (NASDAQ LPNT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2018Q1 2018$1.13$1.22$1.6192 billion$1.6030 billionViewN/AView Earnings Details
2/23/2018Q4 2017$0.81$0.77$1.5803 billion$1.4904 billionViewListenView Earnings Details
10/27/2017Q3 2017$0.95$0.80$1.6035 billion$1.5760 billionViewN/AView Earnings Details
8/1/2017Q2 2017$0.90$0.96$1.6352 billion$1.5948 billionViewListenView Earnings Details
4/28/2017Q1 2017$1.0120$1.07$1.6355 billion$1.6302 billionViewN/AView Earnings Details
2/17/2017Q4 2016$1.07$1.09$1.6332 billion$1.6052 billionViewN/AView Earnings Details
10/28/2016Q316$0.84$0.94$1.59 billion$1.59 billionViewListenView Earnings Details
7/29/2016Q216$0.90$0.71$1.61 billion$1.59 billionViewListenView Earnings Details
4/29/2016Q1$0.88$0.87$1.57 billion$1.58 billionViewListenView Earnings Details
2/12/2016Q415$1.06$1.11$1.3857 billion$1.37 billionViewListenView Earnings Details
10/30/2015Q315$0.90$0.94$1.30 billion$1.31 billionViewListenView Earnings Details
7/31/2015Q215$0.98$1.00$1.24 billion$1.27 billionViewListenView Earnings Details
5/1/2015Q115$1.00$1.00$1.24 billion$1.26 billionViewListenView Earnings Details
2/12/2015Q414$1.01$1.08$1.25 billion$1.26 billionViewListenView Earnings Details
10/24/2014Q314$0.74$0.75$1.09 billion$1.38 billionViewListenView Earnings Details
7/25/2014Q214$0.55$0.84$1.01 billion$1.05 billionViewListenView Earnings Details
4/25/2014Q114$0.65$0.65$1,000.00 million$1.0072 billionViewListenView Earnings Details
2/14/2014Q413$0.80$0.75$952.10 million$952.60 millionViewListenView Earnings Details
10/25/2013Q313$0.66$0.68$891.30 million$899.70 millionViewListenView Earnings Details
7/26/2013Q2 2013$0.72$0.65$911.08 million$894.90 millionViewListenView Earnings Details
4/26/2013Q1 2013$0.81$0.69$924.00 million$931.10 millionViewListenView Earnings Details
2/15/2013Q4 2012$0.65$0.76$863.49 million$893.30 millionViewListenView Earnings Details
10/26/2012Q312$0.76$0.39$814.52 million$820.20 millionViewN/AView Earnings Details
7/27/2012$0.80$0.83ViewN/AView Earnings Details
4/27/2012$0.91$0.94ViewN/AView Earnings Details
2/17/2012Q4 2011$0.76$0.78ViewN/AView Earnings Details
10/28/2011$0.71$0.77ViewN/AView Earnings Details
7/29/2011$0.75$0.77ViewN/AView Earnings Details
4/29/2011$0.81$0.89ViewN/AView Earnings Details
2/18/2011$0.67$0.70ViewN/AView Earnings Details
10/29/2010Q3 2010$0.66$0.73ViewN/AView Earnings Details
8/2/2010Q2 2010$0.63$0.69ViewN/AView Earnings Details
4/30/2010Q1 2010$0.75$0.80ViewN/AView Earnings Details
2/19/2010Q4 2009$0.60$0.73ViewN/AView Earnings Details
11/6/2009Q3 2009$0.56$0.59ViewN/AView Earnings Details
8/7/2009Q2 2009$0.58$0.54ViewN/AView Earnings Details
5/1/2009Q1 2009$0.64$0.74ViewN/AView Earnings Details
2/20/2009Q4 2008$0.63$0.63ViewN/AView Earnings Details
11/7/2008Q3 2008$0.60$0.61ViewN/AView Earnings Details
8/8/2008Q2 2008$0.56$0.60ViewN/AView Earnings Details
5/1/2008Q1 2008$0.61$0.72ViewN/AView Earnings Details
2/8/2008Q4 2007$0.58$0.54ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

LifePoint Health (NASDAQ:LPNT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

LifePoint Health (NASDAQ LPNT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.80%
Insider Trading History for LifePoint Health (NASDAQ:LPNT)
Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

LifePoint Health (NASDAQ LPNT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/28/2018William F Carpenter IIIChairmanBuy21,368$46.80$1,000,022.40482,668View SEC Filing  
1/16/2018David M DillInsiderSell45,000$48.52$2,183,400.00252,673View SEC Filing  
11/28/2017Marguerite KondrackeDirectorSell3,907$44.73$174,760.11View SEC Filing  
11/21/2017Marguerite KondrackeDirectorSell3,416$43.80$149,620.8017,479View SEC Filing  
7/17/2017William F Carpenter IIIChairmanSell17,653$65.06$1,148,504.18439,841View SEC Filing  
6/15/2017William F Carpenter IIIChairmanSell82,347$64.15$5,282,560.05504,535View SEC Filing  
5/11/2017Richard H EvansDirectorSell2,000$62.88$125,760.0017,718View SEC Filing  
3/30/2017John P BumpusEVPSell33,333$65.00$2,166,645.00143,829View SEC Filing  
3/16/2017David M DillInsiderSell18,800$62.22$1,169,736.00207,873View SEC Filing  
3/10/2017David M DillInsiderSell1,200$65.00$78,000.00208,773View SEC Filing  
3/9/2017John P BumpusEVPSell26,362$65.05$1,714,848.10117,458View SEC Filing  
3/6/2017John P BumpusEVPSell305$65.00$19,825.00110,701View SEC Filing  
5/25/2016John E D D S Maupin JrDirectorSell3,800$67.32$255,816.0022,813View SEC Filing  
2/18/2016Gregory T BierDirectorSell2,149$63.00$135,387.0021,339View SEC Filing  
5/7/2015Owen G Shell JrDirectorSell7,500$70.69$530,175.00View SEC Filing  
3/9/2015John E D D S Maupin JrDirectorSell1,300$72.50$94,250.00View SEC Filing  
2/23/2015Michael S CogginSVPSell5,000$70.50$352,500.00View SEC Filing  
9/9/2014Marguerite KondrackeDirectorSell1,500$72.43$108,645.00View SEC Filing  
7/31/2014Leif M MurphyCFOSell100,000$72.03$7,203,000.00View SEC Filing  
6/12/2014Richard H EvansDirectorSell1,000$64.05$64,050.00View SEC Filing  
5/16/2014William Carpenter IIICEOSell280,849$58.11$16,320,135.39374,492View SEC Filing  
5/13/2014Paul GilbertEVPSell54,342$59.21$3,217,589.8220,000View SEC Filing  
5/7/2014John BumpusEVPSell20,000$57.20$1,144,000.0097,901View SEC Filing  
3/12/2014Marguerite KondrackeDirectorSell2,000$51.49$102,980.0023,145View SEC Filing  
12/5/2013Paul GilbertEVPSell12,825$51.12$655,614.0040,000View SEC Filing  
10/31/2013Michael S CogginSVPSell2,000$51.14$102,280.00View SEC Filing  
10/30/2013William F Carpenter IIICEOSell40,000$51.31$2,052,400.00View SEC Filing  
8/1/2013Michael CogginSVPSell2,452$50.00$122,600.0012,435View SEC Filing  
6/6/2013Paul D GilbertEVPSell16,667$51.01$850,183.67View SEC Filing  
5/20/2013Richard H EvansDirectorSell4,275$47.50$203,062.50View SEC Filing  
2/25/2013Michael S CogginSVPSell6,668$44.03$293,592.04View SEC Filing  
2/25/2013Richard H EvansDirectorSell5,000$43.31$216,550.00View SEC Filing  
9/14/2012Marguerite SalleeDirectorSell3,000$42.36$127,080.00View SEC Filing  
8/21/2012Michael S CogginSVPSell6,666$41.00$273,306.00View SEC Filing  
8/21/2012William F Carpenter IIICEOSell50,000$41.02$2,051,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

LifePoint Health (NASDAQ LPNT) News Headlines

Source:
DateHeadline
 Brokerages Anticipate LifePoint Health (LPNT) Will Announce Quarterly Sales of $1.58 Billion Brokerages Anticipate LifePoint Health (LPNT) Will Announce Quarterly Sales of $1.58 Billion
www.americanbankingnews.com - May 21 at 4:18 AM
LifePoint Health (LPNT) Given Consensus Recommendation of "Hold" by AnalystsLifePoint Health (LPNT) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - May 20 at 11:33 AM
Contrasting Quorum Health (QHC) and LifePoint Health (LPNT)Contrasting Quorum Health (QHC) and LifePoint Health (LPNT)
www.americanbankingnews.com - May 19 at 5:15 PM
 Brokerages Expect LifePoint Health (LPNT) Will Post Earnings of $1.08 Per Share Brokerages Expect LifePoint Health (LPNT) Will Post Earnings of $1.08 Per Share
www.americanbankingnews.com - May 19 at 7:28 AM
LifePoint Health to Participate in Barclays High Yield Bond & Syndicated Loan ConferenceLifePoint Health to Participate in Barclays High Yield Bond & Syndicated Loan Conference
finance.yahoo.com - May 16 at 4:45 PM
LifePoint Hospitals (LPNT) Presents At 43rd Annual Deutsche Bank Healthcare Conference - SlidehsowLifePoint Hospitals (LPNT) Presents At 43rd Annual Deutsche Bank Healthcare Conference - Slidehsow
seekingalpha.com - May 10 at 4:54 PM
LifePoint Health (LPNT) Forecasted to Post Q2 2018 Earnings of $1.04 Per ShareLifePoint Health (LPNT) Forecasted to Post Q2 2018 Earnings of $1.04 Per Share
www.americanbankingnews.com - May 10 at 6:51 AM
LifePoint Health to Post Q2 2018 Earnings of $1.10 Per Share, William Blair Forecasts (LPNT)LifePoint Health to Post Q2 2018 Earnings of $1.10 Per Share, William Blair Forecasts (LPNT)
www.americanbankingnews.com - May 9 at 8:40 AM
LifePoint Health (LPNT) Expected to Post FY2018 Earnings of $4.45 Per ShareLifePoint Health (LPNT) Expected to Post FY2018 Earnings of $4.45 Per Share
www.americanbankingnews.com - May 8 at 7:34 AM
SunTrust Banks Reaffirms "Hold" Rating for LifePoint Health (LPNT)SunTrust Banks Reaffirms "Hold" Rating for LifePoint Health (LPNT)
www.americanbankingnews.com - May 7 at 11:27 AM
LifePoint Health (LPNT) Q1 Earnings Beat, Revenues MissLifePoint Health (LPNT) Q1 Earnings Beat, Revenues Miss
www.zacks.com - May 7 at 9:03 AM
LifePoint Health (LPNT) Tops Q1 EPS by 9c, Miss on RevenuesLifePoint Health (LPNT) Tops Q1 EPS by 9c, Miss on Revenues
www.streetinsider.com - May 5 at 9:27 AM
Edited Transcript of LPNT earnings conference call or presentation 4-May-18 2:00pm GMTEdited Transcript of LPNT earnings conference call or presentation 4-May-18 2:00pm GMT
finance.yahoo.com - May 5 at 9:27 AM
Critical Contrast: Quorum Health (QHC) versus LifePoint Health (LPNT)Critical Contrast: Quorum Health (QHC) versus LifePoint Health (LPNT)
www.americanbankingnews.com - May 5 at 3:13 AM
LifePoint Health (LPNT) Releases  Earnings Results, Beats Expectations By $0.09 EPSLifePoint Health (LPNT) Releases Earnings Results, Beats Expectations By $0.09 EPS
www.americanbankingnews.com - May 5 at 12:33 AM
BidaskClub Upgrades LifePoint Health (LPNT) to Strong-BuyBidaskClub Upgrades LifePoint Health (LPNT) to Strong-Buy
www.americanbankingnews.com - May 5 at 12:29 AM
LPNT Makes Bullish Cross Above Critical Moving AverageLPNT Makes Bullish Cross Above Critical Moving Average
www.nasdaq.com - May 4 at 4:39 PM
LifePoint Health (LPNT) Q1 2018 Results - Earnings Call TranscriptLifePoint Health (LPNT) Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 4:39 PM
Should You Buy LifePoint Health (LPNT) Ahead of Earnings?Should You Buy LifePoint Health (LPNT) Ahead of Earnings?
finance.yahoo.com - May 3 at 4:38 PM
LifePoint Health (LPNT) Expected to Announce Quarterly Sales of $1.61 BillionLifePoint Health (LPNT) Expected to Announce Quarterly Sales of $1.61 Billion
www.americanbankingnews.com - May 3 at 2:17 AM
ValuEngine Downgrades LifePoint Health (LPNT) to Strong SellValuEngine Downgrades LifePoint Health (LPNT) to Strong Sell
www.americanbankingnews.com - May 3 at 12:39 AM
 Analysts Expect LifePoint Health (LPNT) Will Announce Earnings of $1.10 Per Share Analysts Expect LifePoint Health (LPNT) Will Announce Earnings of $1.10 Per Share
www.americanbankingnews.com - May 1 at 7:14 PM
LifePoint Health (LPNT) Set to Announce Quarterly Earnings on FridayLifePoint Health (LPNT) Set to Announce Quarterly Earnings on Friday
www.americanbankingnews.com - April 27 at 1:34 AM
LifePoint Health (LPNT) Given Average Recommendation of "Hold" by AnalystsLifePoint Health (LPNT) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - April 25 at 11:28 AM
Can Universal Health (UHS) Q1 Earnings Beat on Admissions?Can Universal Health (UHS) Q1 Earnings Beat on Admissions?
finance.yahoo.com - April 23 at 4:38 PM
LifePoint Health To Broadcast Its First Quarter 2018 Conference Call Live On The InternetLifePoint Health To Broadcast Its First Quarter 2018 Conference Call Live On The Internet
finance.yahoo.com - April 20 at 4:42 PM
LifePoint Health (LPNT) Scheduled to Post Quarterly Earnings on ThursdayLifePoint Health (LPNT) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - April 19 at 2:52 AM
$1.61 Billion in Sales Expected for LifePoint Health (LPNT) This Quarter$1.61 Billion in Sales Expected for LifePoint Health (LPNT) This Quarter
www.americanbankingnews.com - April 16 at 2:17 AM
LifePoint Health (LPNT) Expected to Announce Earnings of $1.10 Per ShareLifePoint Health (LPNT) Expected to Announce Earnings of $1.10 Per Share
www.americanbankingnews.com - April 14 at 9:15 PM
BidaskClub Downgrades LifePoint Health (LPNT) to SellBidaskClub Downgrades LifePoint Health (LPNT) to Sell
www.americanbankingnews.com - April 14 at 5:18 PM
LifePoint Health (LPNT) Rating Reiterated by Piper JaffrayLifePoint Health (LPNT) Rating Reiterated by Piper Jaffray
www.americanbankingnews.com - April 7 at 11:00 PM
LifePoint Health (LPNT) Earns "Hold" Rating from KeyCorpLifePoint Health (LPNT) Earns "Hold" Rating from KeyCorp
www.americanbankingnews.com - April 4 at 3:32 PM
LifePoint Health (LPNT) Given a $55.00 Price Target by Robert W. Baird AnalystsLifePoint Health (LPNT) Given a $55.00 Price Target by Robert W. Baird Analysts
www.americanbankingnews.com - April 4 at 2:27 PM
Castleview Hospital Named Duke LifePoint Quality AffiliateCastleview Hospital Named Duke LifePoint Quality Affiliate
finance.yahoo.com - April 3 at 4:43 PM
Leerink Swann Reiterates "Outperform" Rating for LifePoint Health (LPNT)Leerink Swann Reiterates "Outperform" Rating for LifePoint Health (LPNT)
www.americanbankingnews.com - April 2 at 9:11 PM
LifePoint Health (LPNT) Given a $54.00 Price Target at SunTrust BanksLifePoint Health (LPNT) Given a $54.00 Price Target at SunTrust Banks
www.americanbankingnews.com - April 2 at 8:04 PM
LifePoint Health Inc (LPNT) Receives Average Recommendation of "Hold" from BrokeragesLifePoint Health Inc (LPNT) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - March 31 at 11:34 AM
$1.61 Billion in Sales Expected for LifePoint Health Inc (LPNT) This Quarter$1.61 Billion in Sales Expected for LifePoint Health Inc (LPNT) This Quarter
www.americanbankingnews.com - March 30 at 1:50 AM
Robert W. Baird Reiterates $54.00 Price Target for LifePoint Health (LPNT)Robert W. Baird Reiterates $54.00 Price Target for LifePoint Health (LPNT)
www.americanbankingnews.com - March 27 at 1:18 PM
Wells Fargo Begins Coverage on LifePoint Health (LPNT)Wells Fargo Begins Coverage on LifePoint Health (LPNT)
www.americanbankingnews.com - March 26 at 3:43 PM
Why Is LifePoint Health (LPNT) Down 2.9% Since its Last Earnings Report?Why Is LifePoint Health (LPNT) Down 2.9% Since its Last Earnings Report?
www.zacks.com - March 26 at 9:35 AM
LifePoint Health (LPNT) Upgraded to "Buy" at BidaskClubLifePoint Health (LPNT) Upgraded to "Buy" at BidaskClub
www.americanbankingnews.com - March 24 at 4:30 PM
LifePoint Health (LPNT) Earns Neutral Rating from Analysts at MizuhoLifePoint Health (LPNT) Earns Neutral Rating from Analysts at Mizuho
www.americanbankingnews.com - March 23 at 6:50 PM
Is There Now An Opportunity In LifePoint Health Inc (NASDAQ:LPNT)?Is There Now An Opportunity In LifePoint Health Inc (NASDAQ:LPNT)?
finance.yahoo.com - March 23 at 9:09 AM
LifePoint Health (LPNT) Earns Hold Rating from MizuhoLifePoint Health (LPNT) Earns Hold Rating from Mizuho
www.americanbankingnews.com - March 22 at 9:20 PM
UBS Upgrades LifePoint Health (LPNT) to "Outperform"UBS Upgrades LifePoint Health (LPNT) to "Outperform"
www.americanbankingnews.com - March 17 at 12:32 PM
LifePoint Health, Inc. -- Moodys affirms LifePoints Ba2 CFR, stable outlookLifePoint Health, Inc. -- Moody's affirms LifePoint's Ba2 CFR, stable outlook
finance.yahoo.com - March 16 at 5:40 PM
LifePoint Health (LPNT) Upgraded at Wolfe ResearchLifePoint Health (LPNT) Upgraded at Wolfe Research
www.americanbankingnews.com - March 16 at 2:09 PM
Raymond James Financial Upgrades LifePoint Health (LPNT) to OutperformRaymond James Financial Upgrades LifePoint Health (LPNT) to Outperform
www.americanbankingnews.com - March 15 at 9:58 PM
LifePoint Health Inc (NASDAQ:LPNT): Does The Earnings Decline Make It An Underperformer?LifePoint Health Inc (NASDAQ:LPNT): Does The Earnings Decline Make It An Underperformer?
finance.yahoo.com - March 15 at 9:04 AM

SEC Filings

LifePoint Health (NASDAQ:LPNT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

LifePoint Health (NASDAQ:LPNT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

LifePoint Health (NASDAQ LPNT) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.